|
MCID: MYT002
|
Myotonic Dystrophy malady |
|
Sources: 30NIH Rare Diseases, 17Genetics Home Reference, 44Wikipedia, 33OMIM, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Myotonic dystrophy is an inherited condition that affects the muscles and other body systems. It is the most common form of muscular dystrophy that begins in adulthood; usually during a person's twenties or thirties. This condition is characterized by progressive muscle loss and weakness, particularly in the lower legs, hands, neck, and face. People with myotonic dystrophy often have prolonged muscle tensing (myotonia) and are not able to relax certain muscles after use. The severity of the condition varies widely among affected people, even among members of the same family. There are two types of myotonic dystrophy: myotonic dystrophy type 1 and myotonic dystrophy type 2. The symptoms seen in patients with myotonic dystrophy type 2 tends to be milder than those observed in type 1. Although both types are inherited in an autosomal dominant pattern, they are caused by mutations in different genes. Myotonic dystrophy type 1 is caused by mutations in the DMPK gene, while mutations in the CNBP gene are responsible for myotonic dystrophy type 2.30
MalaCards: Myotonic Dystrophy, also known as dystrophia myotonica, is related to myotonic dystrophy type 1 and myotonic dystrophy type 2. An important gene associated with Myotonic Dystrophy is DMPK (dystrophia myotonica-protein kinase), and among its related pathways are Cytoskeleton remodeling Fibronectin-binding integrins in cell motility and Cell adhesion Integrin-mediated cell adhesion and migration. The compounds glucose and ascorbic acid have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and smooth muscle, and related mouse phenotypes are respiratory system and endocrine/exocrine gland. Genetics Home Reference: Myotonic dystrophy is part of a group of inherited disorders called muscular dystrophies. It is the most common form of muscular dystrophy that begins in adulthood.17 Wikipedia: Myotonic dystrophy (dystrophia myotonica, myotonia atrophica) is a chronic, slowly progressing, highly...44 more... OMIM: 160900 |
|
Sources: 6Disease Ontology, 7diseasecard, 44Wikipedia, 30NIH Rare Diseases, 17Genetics Home Reference, 8DISEASES, 33OMIM, 32Novoseek , 43UMLS, 40SNOMED-CT, 24MeSH, 27NCIt See all sources |
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 160900
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for myotonic dystrophy Drug clinical trials:Search ClinicalTrials for myotonic dystrophy Search NIH Clinical Center for myotonic dystrophy Search CenterWatch for myotonic dystrophy |
|
|
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to myotonic dystrophy:22Brain, Heart, Smooth muscle, Skeletal muscle, Liver, T cells, B cells, Cardiac myocytes
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to myotonic dystrophy:25 (show all 24)
|
|
Sources: 35PubMed See all sources |
Articles related to myotonic dystrophy:(show top 50) (show all 356)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 10EMD Millipore, 41Thomson Reuters, 36QIAGEN, 20KEGG, 3Cell Signaling Technology, 37R&D Systems See all sources |
Pathways related to myotonic dystrophy according to GeneDecks:(show top 50) (show all 140)
|
|
Sources: 32Novoseek , 18HMDB, 9DrugBank, 42Tocris Bioscience, 34PharmGKB See all sources |
Compounds related to myotonic dystrophy according to GeneDecks:(show top 50) (show all 312)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to myotonic dystrophy according to GeneDecks:
Biological processes related to myotonic dystrophy according to GeneDecks:(show all 29)
Molecular functions related to myotonic dystrophy according to GeneDecks:(show all 9)
|
